Expert Review of Clinical Pharmacology [ISSN 1751-2433]; [e-ISSN 1751-2441] is a MEDLINE-indexed, international subscription-based journal publishing rigorously peer-reviewed review articles and original papers on all aspects of clinical safety, tolerability, efficacy and therapeutic applications. Letters to the Editor should discuss articles previously published in the journal.
The journal also covers toxicity issues, adverse reactions, pharmacoeconomics, and societal issues. Adverse reactions experienced at the clinical trial level serve as a constant reminder of the importance of rigorous safety and toxicity testing. Furthermore, the advent of pharmacogenomics and ‘individualized’ approaches to therapy will demand a fresh approach to drug evaluation and healthcare delivery.
Please note that the journal does not publish preclinical or Phase I-II studies, unless there is a clear indication for translational medicine. Each article is structured to incorporate the author's own expert opinion on the impact of the topic on research and clinical practice and the scope for future development.
Expert Review of Clinical Pharmacology aims to address the needs of clinical and pharmaceutical researchers, drug development specialists, physicians, and other specialists and players who are actively meeting such challenges in modern biomedical practice.
The Editors welcome novel research in the following key areas:
- ADME studies and PK/PD modelling
- Novel clinical trial design and conduct
- Toxicity and carcinogenesis
- Adverse effects/reactions, drug–drug and drug–disease interactions
- Pharmacogenetics, genomics and the incorporation of new biomarkers in drug development and clinical practice
- Pharmacoepidemiology, risk management and pharmacovigilance
- Pharmacotherapy in specific groups of people, such as children, women, the immunocompromised, and different ethnicities
- Impact on quality of life and pharmacoeconomic issues
- Regulation of drug development and marketing
- Epidemiology and biostatistics
The journal welcomes:
- Reviews
- Original research
- Editorials
- Drug profiles
- Meta-analyses
- Letters to the Editor
The journal operates a double-anonymized peer review policy.
Comprehensive coverage in each review article is complemented by the unique Expert Collection format and includes the following sections:
Expert Opinion – a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed results.
Article Highlights – an executive summary of the author’s most critical points.
Once your paper has been assessed for suitability by the Editorial Team, it will then be double-anonymous peer-reviewed by independent, expert referees.
Reach an international clinical and medical audience alongside other key option leaders in your field by publishing with Expert Review of Clinical Pharmacology, part of the Expert Collection brand.
Authors can choose to publish gold open access in this journal and may choose to publish using our Accelerated Publication services.
Read the Instructions for Authors for information on how to submit your article. For any pre-submission enquiries, please contact the Commissioning Editor.
![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/110817/Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})